Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study

被引:14
作者
Kim, Seung Jae [1 ]
Kwon, Oh Deog [2 ]
Cho, BeLong [3 ]
Oh, Seung-Won [4 ]
Lee, Cheol Min [4 ]
Choi, Ho-Chun [4 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Family Med, Seoul St Marys Hosp, Seoul, South Korea
[2] ROK Submarine Force Command, Navy Med Off, Chang Won, South Korea
[3] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul, South Korea
来源
BMJ OPEN | 2019年 / 9卷 / 06期
关键词
FIXED-DOSE COMBINATIONS; HEALTH-CARE COSTS; SINGLE-PILL; THERAPY; PERSISTENCE; NONADHERENCE; HYPERTENSION; HOSPITALIZATION; METAANALYSIS; PREVALENCE;
D O I
10.1136/bmjopen-2019-029862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We tried to clarify, by using representative national data in a real-world setting, whether single-pill combinations (SPCs) of antihypertensives actually improve medication adherence. Design A nationwide population-based study. Setting We used a 2.2% cohort (n=1 048 061) of the total population (n=46 605 433) that was randomly extracted by National Health Insurance of Korea from 2008 to 2013. Participants We included patients (n=116677) who were prescribed with the same antihypertensive drugs for at least 1 year and divided them into groups of angiotensin II receptor blocker (ARB)-only, calcium channel blocker (CCB)-only, multiple-pill combinations (MPCs) and SPCs of ARB/CCB. Primary outcome measures Medication possession ratio (MPR), a frequently used indirect measurement method of medication adherence. Results Adjusted MPR was higher in combination therapy (89.7% in SPC, 87.2% in MPC) than monotherapy (81.6% in ARB, 79.7% in CCB), and MPR of SPC (89.7%, 95% CI 89.3 to 90.0) was higher than MPR of MPC (87.2%, 95% CI 86.7 to 87.7) (p<0.05). In subgroup analysis, adherence of SPC and MPC was 92.3% (95% CI 91.5 to 93.0) vs 88.1% (95% CI 87.1 to 89.0) in those aged 65-74 years and 89.3% (95% CI 88.0 to 90.7) vs 84.8% (95% CI 83.3 to 92.0) in those >= 75 years (p<0.05). According to total pill numbers, adherence of SPC and MPC was 90.9% (CI 89.8 to 92.0) vs 85.3% (95% CI 84.1 to 86.5) in seven to eight pills and 91.2% (95% CI 89.3 to 93.1) vs 82.5% (95% CI 80.6 to 84.4) in nine or more (p<0.05). The adherence difference between SPC and MPC started to increase at five to six pills and at age 50-64 years (p<0.05). When analysed according to elderly status, the adherence difference started to increase at three to four pills in the elderly (>= 65 years) and at five to six in the non elderly group (20-64 years) (p<0.05). These differences all widened further with increasing age and the total medications. Conclusion SPC regimens demonstrated higher adherence than MPC, and this tendency is more pronounced with increasing age and the total number of medications.
引用
收藏
页数:10
相关论文
共 37 条
[1]   Methods for evaluation of medication adherence and persistence using automated databases [J].
Andrade, Susan E. ;
Kahler, Kristijan H. ;
Frech, Feride ;
Chan, K. Arnold .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (08) :565-574
[2]  
[Anonymous], 2003, Adherence to Long-Term Therapies: Evidence for action
[3]   Fixed-dose combinations improve medication compliance: A meta-analysis [J].
Bangalore, Sripal ;
Kamalakkannan, Gayathri ;
Parkar, Sanobar ;
Messerli, Franz H. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (08) :713-719
[4]  
Baser Onur, 2011, J Med Econ, V14, P576, DOI 10.3111/13696998.2011.596873
[5]   The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs [J].
Billups, SJ ;
Malone, DC ;
Carter, BL .
PHARMACOTHERAPY, 2000, 20 (08) :941-949
[6]   US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008 [J].
Egan, Brent M. ;
Zhao, Yumin ;
Axon, R. Neal .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (20) :2043-2050
[7]   Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents A Meta-Analysis [J].
Gupta, Ajay K. ;
Arshad, Shazia ;
Poulter, Neil R. .
HYPERTENSION, 2010, 55 (02) :399-407
[8]   Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data [J].
Halpern, Michael T. ;
Khan, Zeba M. ;
Schmier, Jordana K. ;
Burnier, Michel ;
Caro, J. Jaime ;
Cramer, Joyce ;
Daley, William L. ;
Gurwitz, Jerry ;
Hollenberg, Norman K. .
HYPERTENSION, 2006, 47 (06) :1039-1048
[9]   Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan [J].
Hashmi, Saman K. ;
Afridi, Maria B. ;
Abbas, Kanza ;
Sajwani, Rubina A. ;
Saleheen, Danish ;
Frossard, Philippe M. ;
Ishaq, Mohammad ;
Ambreen, Aisha ;
Ahmad, Usman .
PLOS ONE, 2007, 2 (03)
[10]   Medication Adherence Its Importance in Cardiovascular Outcomes [J].
Ho, P. Michael ;
Bryson, Chris L. ;
Rumsfeld, John S. .
CIRCULATION, 2009, 119 (23) :3028-3035